These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 12006336

  • 1. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
    Triolo G, Vadalà M, Accardo-Palumbo A, Ferrante A, Ciccia F, Giardina E, Citarrella P, Lodato G, Licata G.
    Ann Rheum Dis; 2002 Jun; 61(6):560-1. PubMed ID: 12006336
    [No Abstract] [Full Text] [Related]

  • 2. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH, Kwok SK, Seo SH, Yoon CH, Kim HY, Park SH.
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
    Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G.
    Ann Rheum Dis; 2003 Mar; 62(3):280-1. PubMed ID: 12594127
    [No Abstract] [Full Text] [Related]

  • 4. Remission of Behçet's syndrome with TNFalpha blocking treatment.
    Rozenbaum M, Rosner I, Portnoy E.
    Ann Rheum Dis; 2002 Mar; 61(3):283-4. PubMed ID: 11830448
    [No Abstract] [Full Text] [Related]

  • 5. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
    Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN.
    Lancet; 2001 Jul 28; 358(9278):295-6. PubMed ID: 11498218
    [Abstract] [Full Text] [Related]

  • 6. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome.
    Seyahi E, Hamuryudan V, Hatemi G, Melikoglu M, Celik S, Fresko I, Yurdakul S, Yazici H.
    Rheumatology (Oxford); 2007 Jul 28; 46(7):1213-4. PubMed ID: 17478465
    [No Abstract] [Full Text] [Related]

  • 7. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I.
    Clin Exp Rheumatol; 2010 Jul 28; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
    Andreu M, Ramanoelina J, Fajnkuchen F, Mouthon L, Cohen P, Laroche L, Guillevin L.
    Ann Med Interne (Paris); 2002 Oct 28; 153(6):414-5. PubMed ID: 12486393
    [No Abstract] [Full Text] [Related]

  • 11. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M, Cinal A, Topcu N, Demirok A.
    Ann Pharmacother; 2004 May 28; 38(5):901-2. PubMed ID: 15010522
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease.
    Rosenbaum JT.
    J Rheumatol; 2004 Jul 28; 31(7):1241-3. PubMed ID: 15229938
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G, Velken M, Johnsen V.
    Ann Rheum Dis; 2004 Jun 28; 63(6):744-5. PubMed ID: 15140785
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
    Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G.
    J Rheumatol; 2004 Jul 28; 31(7):1362-8. PubMed ID: 15229958
    [Abstract] [Full Text] [Related]

  • 17. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B, Sablé-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O, LeHoang P, Piette JC.
    Clin Exp Rheumatol; 2004 Jul 28; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [Abstract] [Full Text] [Related]

  • 18. [Spondylarthropathy with Behçet's disease: response to infliximab].
    Toussirot E, Schwartz C, Hafsaoui C, Bossert M, Bertolini E, Wendling D.
    Presse Med; 2009 Jul 28; 38(7-8):1183-5. PubMed ID: 19395229
    [No Abstract] [Full Text] [Related]

  • 19. [Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease].
    Tanaka H, Sugita S, Yamada Y, Kawaguchi T, Iwanaga Y, Kamoi K, Yokota M, Takase H, Mochizuki M.
    Nippon Ganka Gakkai Zasshi; 2010 Feb 28; 114(2):87-95. PubMed ID: 20187505
    [Abstract] [Full Text] [Related]

  • 20. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I, Deuter C, Stubiger N, Zierhut M.
    J Rheumatol; 2005 Aug 28; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.